Cargando…
EMBRACE: One Small Story in Lupus—One Giant Challenge in Clinical Trials
Clinical trials of novel therapeutics in the United States have not been adequately representative of diverse populations, particularly racial and ethnic minorities. The challenges and consequences of underrepresentation in clinical trial recruitment are exemplified by the case of belimumab, a biolo...
Autores principales: | Sheikh, Saira Z., Englund, Tessa R., Burriss, Susan W., Bull, Jonca, Harry, Anya, Groark, James G., Hall, Ashley M., Miller, Michelle, Roth, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469483/ https://www.ncbi.nlm.nih.gov/pubmed/35748175 http://dx.doi.org/10.1002/acr2.11477 |
Ejemplares similares
-
Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus
por: Sheikh, Saira Z., et al.
Publicado: (2016) -
Phase III/IV, Randomized, Fifty‐Two–Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus
por: Ginzler, Ellen, et al.
Publicado: (2021) -
One-Story versus Many-Story Methods
Publicado: (1919) -
ACT for Lupus: Pilot Feasibility and Acceptability Study of a Novel Web‐Based Acceptance and Commitment Therapy Program for Patients With Lupus
por: McCormick, Emily M., et al.
Publicado: (2022) -
Teratogenic medication use associated with favourable odds of contraception counselling in a cohort of women with systemic lupus erythematosus at a large tertiary academic medical centre
por: Chandramouli, Shruti, et al.
Publicado: (2022)